NEORX CORP
S-3/A, EX-23.1, 2000-08-31
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: NEORX CORP, S-3/A, 2000-08-31
Next: WARBURG PINCUS CASH RESERVE FUND, N-30D, 2000-08-31



<PAGE>   1
                                  Exhibit 23.1

               CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS


The Board of Directors
NeoRx Corporation:

        We consent to the use of our report incorporated herein by reference and
to the reference to our firm under the heading "Experts" in the prospectus.



                                            /s/ KPMG LLP
                                            ------------------------------------
                                            KPMG LLP

Seattle, Washington


August 29, 2000




                                      II-5


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission